Treatment of minimal brain dysfunction (MBD)

Details Treatment of minimal brain dysfunction (MBD) Treatment of minimal brain dysfunction (MBD)

1982-07-06

1984-03-06

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

A61K 31135

Patent

active

044354495

ABSTRACT:
A method of Treatment of Minimal Brain Dysfunction (MBD) also known as ATTENTION DEFICIT DISORDER in humans by the administration of the compound of the formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof in a non-toxic, effective therapeutic amount (calculated as base) to a human in need thereof.

REFERENCES:
patent: 3819706 (1974-06-01), Mehta
patent: 3885046 (1975-05-01), Mehta
Stern, Chem. Abst., vol. 92, 1980-34480.
Canning et al., British J. of Pharmacology, (1979), 66, 104-105.
Communications, J. Pharm. Pharmac. (1977), 29, pp. 767-770.
Stern et al., Life Sciences, vol. 25, pp. 17-17-1724.
Whiteman et al., J. Clin. Psychiatry, (1982), Failure of Bupropion to Affect Prolactin or Growth Hormone.
Pharmacological and Biochemical Properties of Drug Substances, vol. 3, "Bupropion", R. A. Maxwell et al., Amer. Pharm. Ass. Academy of Pharm. Sciences-Publisher
Studies Concerning the Mechanism of the Antidepressant Activity of Bupropion, R. M. Ferris, J. Clin. Psychiatry (1982).
R. M. Ferris et al., Drug Development Research, 1:21-35, (1981).
Laakmann et al., Life Sciences, vol. 30, pp. 1725-1732.
Butz et al., Impess: Jour. of Exp. Pharm. & Therapeutics (1982), The Relationship Between Bupropion Disposition and Dopamine Uptake in Rats and Mice.
Neurochemical and Neuropharmacological Investigations into the Mechanisms of Action of Bupropion-HCl-A New Atypical Antidepressant Agent, Ferris et al., Typical and Atypical Antidepressants, Molecular Mechanisms, Raven Press, N.Y. (1982).

Affiliated with

Also associated with

Rating

Treatment of minimal brain dysfunction (MBD) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of minimal brain dysfunction (MBD), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of minimal brain dysfunction (MBD) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-741769